期刊文献+

包裹液态氟碳高分子纳米球相变及体外超声显影 被引量:7

Phase change of polymeric nanocapsules with liquid perfluorocarbons and in vitro ultrasound imaging
下载PDF
导出
摘要 目的制备一种新型纳米级超声造影剂——液态氟碳(PFP)高分子纳米球,观察其物理特性、体外热致相变、声致相变及体外超声显影效果。方法采用乳化-蒸发法(单乳化法)制备包裹PFP的MPEG-PLGA纳米球(P-NP),以光镜观察纳米球形态分布,以纳米粒度及Zeta电位分析仪检测纳米球粒径和电位;在显微镜上放置加热板实时观察P-NP的相变情况;于体外应用低强度聚焦超声(LIFU)仪辐照后,观察其超声显影效果。结果所制备的包裹PFP的高分子纳米球外观为乳白色混悬液,形态规则,呈球包球形;平均粒径为(393.2±40.7)nm,平均电位为(-5.23±8.69)mV;加热板显示的温度约为42.6℃时,光镜下显示纳米球开始转变为微气泡,且随着温度增高,所产生的气泡逐渐增多;体外行LIFU辐照后,在超声基波和谐波模式下可观察到显影明显增强。结论成功制备了PFP高分子纳米球,其粒径小、稳定性好,体外经LIFU仪辐照后可增强超声显影,有望成为一种新型超声造影剂。 Objective To prepare a new ultrasound contrast agent polymeric nanocapsules of liquid perfluorocarbons (P- NP), and to observe its physical characteristics, phase change by heating or ultrasound and effect on ultrasound imaging in vitro. Methods P-NP was prepared by using emulsion solvent-evaporation process. The morphology and distribution were observed with optical microscope. The size and electric potential were obtained by using nano-zetasizer. The phase change of nanocapsules of liquid perfluorocarbons on heatingplate was observed by optical microscope instantaneously. After using low intensity focused ultrasound (LIFU), the effect on ultrasound imaging was observed in vitro. Results The prepared polymeric nanocapsules of PFP was opacified suspension in appearance, the distribution and size were uniformed with core- shell structure, with the average size and potential of (393.2± 40.7) nm and ( -- 5.23 ± 8.69) mV, respectively. When heatingplate showed 42.6℃, the phase change of nanocapsules had just begun, and the higher the temperature was, the more bubbles formed. After LIFU ablation, P-NP of obvious enhancement of ultrasound imaging was observed under the model of fundamental and harmonic wave in vitro. Conclusion P-NP can be successfully prepared using the above method, and can enhance ultrasound imaging after LIFU ablation in vitro, which may become a new type of ultrasound contrast agent.
出处 《中国介入影像与治疗学》 CSCD 2013年第11期679-683,共5页 Chinese Journal of Interventional Imaging and Therapy
基金 国家自然科学基金面上项目(81071157) 重庆市高校创新团队计划(KJTD201303)
关键词 液态氟碳 纳米球 相变 造影剂 Liquid perfluorocarbons~ Nanocapsules~ Phase-change~ Contrast media
  • 相关文献

参考文献13

  • 1李奥,王志刚.液态氟碳纳米粒——一种多功能影像学造影剂[J].临床超声医学杂志,2008,10(12):830-832. 被引量:15
  • 2周洋,王志刚.液态氟碳相变的研究进展[J].临床超声医学杂志,2012,14(6):402-405. 被引量:10
  • 3Kaneda MM, Caruthers S, Lanza GM, et al. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics. Ann Biomed Eng, 2009,37(10):1922-1933.
  • 4Kornmann LM, Curls I)M, Hermeling E, et al. Perfluorohexane- loaded macrophages as a novel ultrasound contrast agent : A feasi- bility study. Mol Imaging Biol, 2008, 10(5):264 270.
  • 5Saha P, Modarai B, Humphries J, et al. The monocyte/macro- phage as a therapeutic target in atherosclerosis. Curr Opin Phar- macol, 2009,9(2) : 109-118.
  • 6Schad KC, Hynynen K: In vitro characterization of perfluorocar- bon droplets for focused ultrasound therapy. P hys Med Biol, 2010,55(17) :4933-4947.
  • 7沈红霞,郑元义,周洋,赵建龙,罗银灯,王志刚.包裹液态氟碳的高分子超声造影剂的制备及体外显影实验[J].中国介入影像与治疗学,2012,9(4):291-294. 被引量:11
  • 8Diaz-L6pez R, Tsapis N, Fattal E. Liquid perf|uorocarbons as contrast agents for ultrasonography and (19) F-MRI. Pharm Res, 2010,27(1):1-16.
  • 9Ragde H, Kenny GM, Murphy GP, et al. Transrectal ultrasound microbubble contrast angiography of the prostate. Prostate,1997,32 (4) : 279-283.
  • 10Rapoport NY, Efros AL, Christensen DA, et al. Microbubble Generation in Phase-Shift Nanoemulsions used as Anticancer Drug Carriers. Bubble Sci Eng Technol, 2009,1(1-2):31 39.

二级参考文献64

  • 1冉海涛,任红,王志刚,郑元义,张群霞,许川山.自制高分子聚合材料超声造影剂显影效果动物实验研究[J].中华超声影像学杂志,2006,15(5):378-380. 被引量:11
  • 2伍星,王志刚,许川山.纳米级造影剂在超声分子显像与靶向治疗中的研究进展[J].中华超声影像学杂志,2006,15(7):539-540. 被引量:13
  • 3张勇,王志刚,许川山.纳米抗体:一种潜力巨大的超声造影剂靶向分子[J].中华超声影像学杂志,2007,16(2):171-172. 被引量:4
  • 4Clark LC, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science, 1966, 152 (730) : 1755 - 1756.
  • 5Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Probl Cardiol, 2003,28 (12) : 625 - 653.
  • 6Hughes MS, Marsh JN, Hall CS, et al. Acoustic characterization in whole blood and plasma of site - targeted nanopartiele ultrasound contrast agent for molecular imaging. Acoust Soc Am, 2005,117 (12) : 1964 - 1972.
  • 7Marsh JN,Hail CS,Scott MJ,et al. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model.IEEE Trans Ultrasan Ferroelectr Freq Control,2000,49(1) :29- 38.
  • 8Hall CS, Marsh JN, Scott M J, et al. Temperature dependence of ultrasonic enhancement with a site- targeted contrast agent. J Acoust Soc Am,2001, 110(3 Pt 1):1677-1684.
  • 9Marsh JN, Hall CS, Wickline SA, et al. Temperature dependence of acoustic impedance for specific fluorocarbon liquids. J Acoust Soc Am, 2002,112(6) :2858 - 2862.
  • 10Marsh JN, Partlow KC, Abendschein DR, et al. Molecular imaging with targted prefluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes. Ultrasound in Med & Biol,2007,33(6):950- 958.

共引文献32

同被引文献73

  • 1许乙凯,刘岘,叶靖.二步法预定位技术对荷人肝癌裸鼠模型的MR免疫成像研究[J].中华放射学杂志,2005,39(4):357-361. 被引量:6
  • 2王志刚.超声微泡造影剂在疾病诊断与治疗中的研究进展[J].中国医学影像技术,2005,21(8):1148-1150. 被引量:46
  • 3Kripfgans OD, Fowlkes JB, Miller DL, et al. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultra- sound Med Biol, 2000,26(7):1177-1189.
  • 4Rapoport N. Phase-shift, stimuli-responsive perfluorocarbon nan- odroplets for drug delivery to cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2012,4(5) :492-510.
  • 5Zhou Y, Wang Z, Chen Y, et al. Microbubbles from gas-genera- ting perfluorohexane nanoemulsions for targeted temperature-sen- sitive ultrasonography and synergistic HIFU ablation of tumors. Adv Mater, 2013,25(30) :4123-4130.
  • 6Li P, Zheng Y, Ran H, et al. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice. J Control Release, 2012,162 (2) :349-354.
  • 7Rapoport NY, Efros AL, Christensen DA, et al. Microbubble generation in phase-shift nanoemulsions used as anticancer drug carriers. Bubble Sci Eng Technol, 2009,1(1-2):31-39.
  • 8Ferrara KW. Driving delivery vehicles with ultrasound. Adv Drug Deliv Rev, 2008,60(10) : 1097-1102.
  • 9Rapoport N, Nam KH, Gupta R, et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copoly- met stabilized perfluorocarbon nanoemulsions. J Control Release, 2011, 153(1) :4-15.
  • 10Huang SL, MacDonald RC. Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta, 2004,1665(1) :184-141.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部